Although the data still await full publication, a meeting abstract reports the effectiveness of the STAT3 inhibitor, WP1066 in inhibiting migration of DIPG primary cells, as well as reducing tumor burden and enhancing survival in a xenograft DIPG model (57). The gene discussed is STAT3; the disease is diffuse intrinsic pontine glioma.